Global Retirement Partners’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$107K Buy
+437
New +$94.8K ﹤0.01% 2007
2025
Q4
$78.5K Buy
430
+345
+406% +$48.2K ﹤0.01% 2060
2025
Q3
$10.3K Hold
85
– – ﹤0.01% 2686
2025
Q2
$8.87K Buy
+85
New +$9K ﹤0.01% 2662
2024
Q4
$6.18K Sell
73
-24
-25% -$2.21K ﹤0.01% 2589
2024
Q3
$8.72K Sell
97
-80
-45% -$6.98K ﹤0.01% 2345
2024
Q2
$14.2K Buy
177
+154
+670% +$11.4K ﹤0.01% 2151
2024
Q1
$1.83K Buy
23
+18
+360% +$1.51K ﹤0.01% 2779
2023
Q4
$425 Buy
+5
New +$334 ﹤0.01% 3118

Other funds holding AXSM

Global Retirement Partners's AXSM Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 437 shares worth $107K. The stake represents ﹤0.01% of the portfolio and ranks #2007 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in AXSM as recently as Q4 2025.

Global Retirement Partners first reported a position in AXSM in Q4 2023 and has held it in 9 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Global Retirement Partners held 437 shares of Axsome Therapeutics worth $107K as of Q2 2026.
  • Axsome Therapeutics was a new Global Retirement Partners position in Q2 2026.
  • Axsome Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #2007 holding.
  • Global Retirement Partners first reported a position in Axsome Therapeutics in Q4 2023 and has held it in 9 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.